Rise and fall of HCV-related hepatocellular carcinoma in Italy: A long-term survey from the ITA.LI.CA centres

Liver International

Volumn 33, Issue 9, 2013, Pages 1420-1427

  Cazzagon, Nora ^a   Trevisani, Franco ^b   Maddalo, Gemma ^c   Giacomin, Anna ^a   Vanin, Veronica ^a   Pozzan, Caterina ^a   Poggio, Paolo Del ^d   Rapaccini, Gianludovico ^e   Nolfo, Anna M Di ^f   Benvegnù, Luisa ^a   Zoli, Marco ^b   Borzio, Franco ^g   Giannini, Edoardo G ^h   Caturelli, Eugenio ⁱ   Chiaramonte, Maria ^j   Foschi, Francesco G ^k   Cabibbo, Giuseppe ^l   Felder, Martina ^m   Ciccarese, Francesca ⁿ   Missale, Gabriele ^o   Baroni, Gianluca Svegliati ^p   Morisco, Filomena ^q   Pecorelli, Anna ^b   Farinati, Fabio ^a   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d TREVIGLIO HOSPITAL   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f BOLOGNINI HOSPITAL   (Italy)

^g FATEBENEFRATELLI HOSPITAL   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ BELCOLLE HOSPITAL   (Italy)

^j SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^k OSPEDALE DEGLI INFERMI   (Italy)

^l Divisione Medicina Interna e Specialistica   (Italy)

^m Ospedale di Bolzano   (Italy)

ⁿ Divisione di Chirurgia   (Italy)

^o Dipartimento Oncoematologico ed Internistico Malattie Infettive ed Epatologia   (Italy)

^p UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^q UNIVERSITY OF NAPLES FEDERICO II   (Italy)

more..

Author keywords

Cirrhosis; Hepatitis C; Hepatocellular carcinoma

Indexed keywords

AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; ITALY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; VEIN THROMBOSIS;

CIRRHOSIS; HEPATITIS C; HEPATOCELLULAR CARCINOMA;

AGE FACTORS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C; HUMANS; INCIDENCE; ITALY; LIVER NEOPLASMS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 84883754278     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12208     Document Type: Article

References (39)

1. El Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76.
2. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-907.
3. Ferlay J, Shin HK, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
4. Bosch FX, Ribes J, Cleries R, Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liv Dis 2005; 9: 191-211.
5. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22.700 men in Taiwan. Lancet 1981; 2: 1129-33.
6. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26: 6266-73.
7. Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009; 19: 231-4.
8. Chan CY, Lee SD, Lo KJ. Legend of hepatitis B vaccination: the Taiwan experience. J Gastroenterol Hepatol 2004; 19: 121-6.
9. Viviani S, Jack A, Hall AJ, et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 1999; 17: 2946-50.
10. Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550-7.
11. Bonanni P, Pesavento G, Bechini A, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 2003; 21: 685-91.
12. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002; 62(Suppl. 1): 8-17.
13. Bosetti C, Levi F, Boffetta P, et al. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008; 48: 137-45.
14. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16.
15. Brechot C, Jaffredo F, Lagorce D, et al. Impact of HBV, HCV and GBV-C/HCV on hepatocellular carcinoma in Europe: results of a European concerted action. J Hepatol 1998; 29: 173-83.
16. World Health Organization Statistical Information System. Hepatitis C: global prevalence (update). WKJ Epidemiol Rec 1999; 74: 425-7.
17. Bosetti C, Bianchi C, Negri E, Colombo M, La Vecchia C. Estimates of the incidence and prevalence of hepatocellular carcinoma in Italy 2002 and projections for the years 2007 and 2012. Tumori 2009; 95: 23-7.
18. Sweeting MJ, Hope VD, Hickman M, et al. Hepatitis C infection among injecting drug users in England and Wales (1992-2006): there and back again? Am J Epidemiol 2009; 170: 352-60.
19. Judd A, Hickman M, Jones S, et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ 2005; 330: 24-5.
20. Sutton AJ, Hope VD, Mathei C, et al. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. J Viral Hepat 2008; 15: 809-16.
21. West J, Wood H, Logan RF, Quinn M, Aithal GP, et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006; 94: 1751-8.
22. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma; a retrospective study of 435 patients. Hepatology 1998; 28: 751-5.
23. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
24. Commissione Epatocarcinoma dell'Associazione Italiana per lo Studio del Fegato. Epatocarcinoma: Linee Guida per la Diagnosi e la Terapia. Bologna: Tipografia Moderna; 1998.
25. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001; 35: 421-30.
26. Trevisani F, De Notariis S, Rapaccini G, et al.; The Italian Liver Cancer Group. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patients survival (Italian experience). Am J Gastroenterol 2002; 97: 734-44.
27. Trevisani F, Caraceni P, Bernardi M, et al. Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993; 72: 1557-63.
28. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
29. Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future. Semin Cancer Biol 2011; 21: 59-69.
30. Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect 2010; 118: 818-24.
31. Baldo V, Baldovin T, Trivello R, Floreani A. Epidemiology of HCV infection. Curr Pharm Des 2008; 14: 1646-54.
32. Farinati F, Giacomin A, Vanin V, et al.; Italian Liver Cancer (ITA.LI.CA) group. Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy. Eur J Gastroenterol Hepatol 2012; 24: 195-202.
33. Borzio M, Fornari F, De Sio I, et al. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. Future Oncol 2013; 9: 283-94.
34. Bruix J, Calvet X, Costa J, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 8670: 1004-6.
35. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 8670: 1006-8.
36. Chiaramonte M, Farinati F, Fagiuoli S, et al. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990; 335: 300-2.
37. Giannini EG, Savarino V, Risso D, et al.; for the Italian Liver Cancer (ITA.LI.CA.) group. Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study. Liver Int 2011; 31: 192-6.
38. Stroffolini T, Trevisani F, Pinzello G, et al. Changing aetiological factors of hepatocellular carcinoma and their potential impact the effectiveness of surveillance. Dig Liv Dis 2011; 43: 875-90.
39. Farinati F, Fagiuoli S, De Maria N, et al. Anti-HCV positive hepatocellular carcinoma in cirrhosis: prevalence, risk factors and clinical features. J Hepatol 1992; 14: 183-7.